SSA
AMAM

Schonfeld Strategic Advisors’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History

Schonfeld Strategic Advisors’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-263,743
Closed -$3.76M – 2297
2023
Q4 		$3.76M Buy
+263,743
New +$3.76M 0.02% 540
2023
Q3 		– Sell
-98,600
Closed -$1.62M – 2239
2023
Q2 		$1.62M Buy
98,600
+20,400
+26% +$336K 0.01% 814
2023
Q1 		$698K Buy
+78,200
New +$698K 0.01% 1055